Medical Xpress

MARCH 9, 2023

Researchers have analyzed image and genomic data from the UK Biobank to find insights into rare diseases of the human eye. These include retinal dystrophies—a group of inherited disorders affecting the retina—which are also the leading cause of blindness certification in working-age adults.

Biobanking 75

Biobanking Genomics Genome Research 75

Pharmaceutical Technology

JUNE 20, 2023

The new AIID building will include a human infection challenge unit, high-containment facilities, a robotic biobanking facility, interview rooms, dry laboratories and spaces for community engagement and co-design work. It will be connected across multiple levels to the University of Melbourne’s Doherty Institute.

Biobanking 130

Biobanking Genomics Genome Clinical Trials 130

XTalks

SEPTEMBER 16, 2022

Researchers at the Francis Crick Institute and University College London in the UK have found how air pollution can trigger the activation of cells with existing genetic mutations to form cancer. The researchers propose that particulate matter 2.5 The new research shows that air pollutants can be that ‘second hit.’

Research 97

Research Gene Scientist Biobanking 97

Scienmag

NOVEMBER 12, 2020

In a study that has unprecedented implications to advance both medicine and biodiversity conservation, researchers have sequenced 131 new placental mammal genomes, bringing the worldwide total to more than 250 In a study that has unprecedented implications to advance both medicine and biodiversity conservation, researchers have sequenced 131 new placental (..)

Biobanking 41

Biobanking Medicine Genomics Genome 41

pharmaphorum

DECEMBER 2, 2021

GlaxoSmithKline has formed a five-year partnership with Oxford University to set up a new institute that will apply machine learning and functional genomics to the discovery of new medicines. ” The post GSK pumps £30m into a new Oxford University partnership appeared first on.

Biobanking 93

Biobanking Genomics Genome Genetics 93

The Pharma Data

MARCH 1, 2022

to build a scalable data, analytics, and infrastructure platform This collaboration aims at capturing translational disease insights from large external healthcare biobanks and maximizing value of data for drug discovery and precision medicine. Boehringer Ingelheim partners with Lifebit Biotech, Ltd.

Biobanking 52

Biobanking Genomics Genome Genome Project 52

pharmaphorum

JANUARY 24, 2023

One of the reasons is because researchers now have far more genetic data to work with than was ever previously possible. The cost of testing per human genome in 2006 was approximately $14 million , and in less than two decades, an average consumer-purchased genetic test costs $100.

Genetics 98

Genetics Drugs Genome Project Biobanking 98

pharmaphorum

MARCH 19, 2021

on Big data: astronomical or genomical? , by 2025 more than 500 million human genomes will be sequenced, creating more data than YouTube and Twitter combined. According to an article by Stephens, Zachary D.,

Bioinformatics 59

Bioinformatics Drugs Genomics Genome 59

The Pharma Data

JULY 15, 2021

Managed by the Broad Institute of MIT and Harvard, the browser gives access to results from analyses of whole exome sequencing data from 300,000 UK Biobank research participants. (Nasdaq: BIIB) and Pfizer (NYSE: PFE). These genetic data have been paired with detailed health information to create this browsable resource.

Biobanking 52

Biobanking Genetics Protein Medicine 52

Trialfacts

SEPTEMBER 12, 2024

By participating, you can help researchers uncover crucial insights that could lead to better, more effective therapies for AD. Join this research study to potentially improve the future treatment and care of those living with atopic dermatitis. Participants will be helping to advance medical research. Why Participate?

Research 52

Research Gene Editing Biobanking Bioinformatics 52

XTalks

APRIL 15, 2021

New advances in heart failure genomics are helping to address this challenge. Experts from Servier and Genuity Science recently spoke on a webinar about using genomics data to drive drug development in heart failure and identify new targets for novel therapeutics. Watch this on-demand webinar to hear from these experts.

Development 98

Development Drugs Genomics Genome 98

The Pharma Data

JULY 8, 2021

Managed by the Broad Institute of MIT and Harvard, the browser gives access to results from analyses of whole exome sequencing data from 300,000 UK Biobank research participants. (Nasdaq: BIIB) and Pfizer (NYSE: PFE). These genetic data have been paired with detailed health information to create this browsable resource.

Genetics 52

Genetics Biobanking Protein Containment 52

pharmaphorum

JULY 5, 2022

George Freeman, minister for science, research and innovation at the Department for Business, Energy and Industrial Strategy, opened proceedings by reminding us of some of the UK’s recent achievements and aspirations for the future. Faster access for patients for interventions. Data on all aspects, including stratification of patient types.

Life Science 98

Life Science Medicine Biobanking Research 98

The Pharma Data

APRIL 11, 2023

Bayer is progressing novel research around its prostate cancer treatment darolutamide. Both small molecule inhibitors in Immuno-Oncology are being jointly developed in a strategic research alliance with the German Cancer Research Center (DKFZ) in Heidelberg, Germany.

Research 40

Research Clinical Trials Clinical Trials Trials 40

The Pharma Data

JANUARY 20, 2021

The UK biobank released a further dataset on COVID-19 positive patients consisting of ~4,000 confirmed COVID-19 infected patients in November 2020. The laboratory reagents are being independently cross validated at the Australian Genome Research facility (AGRF).

Genetics 40

Genetics Reagent Biobanking Production 40